Multimedialna platforma wiedzy medycznej Internetowa Księgarnia Medyczna Kalendarium Konferencji
Rheumatology Forum
MENU
Shortcuts Submit an article Author Guidelines Ahead Of Print Editorial Team

open access

Vol 3, No 2 (2017)
Review paper
Published online: 2017-06-20
View PDF (Polish) Download PDF file
Get Citation

Kacheksja reumatoidalna

Magdalena Krajewska-Włodarczyk, Włodzimierz Samborski
Forum Reumatol 2017;3(2):65-71.

open access

Vol 3, No 2 (2017)
Review
Published online: 2017-06-20

Abstract

Wyniszczenie jest wynikiem długotrwałego złożonego procesu patologicznego, w którym dochodzi do utraty tkanki mięśniowej, tłuszczowej i kostnej. Konsekwencją ubytku masy mięśniowej jest osłabienie siły mięśniowej i sprawności fizycznej, prowadząc do wzrostu ryzyka upadków co przy ubytku tkanki kostnej prowadzi do wzrostu ryzyka złamań i ich powikłań. Obecnie nie jest znany mechanizm prowadzący do wyniszczenia, ale zwraca się dodatkowo uwagę na wzrost spoczynkowego wydatku energetycznego, wzmożony katabolizm białkowy oraz nadprodukcję cytokin prozapalnych. Kacheksja w reumatoidalnym zapaleniu stawów uważana jest za czynnik pogarszający rokowanie zarówno co do przebiegu choroby, jak i przeżycia. Nie ma dotychczas opracowanych standardów postępowania leczniczego w kacheksji reumatoidalnej. Ćwiczenia wytrzymałościowe i siłowe, dostosowane do aktualnego stanu chorych, wydają się najbardziej skuteczną metodą zapobiegania utracie masy mięśniowej, natomiast wyniszczenie w przebiegu reumatologicznego zapalenia stawów wydaje się być oporne na terapię żywieniową i rozwija się nawet wobec prawidłowo zbilansowanej diety.

Abstract

Wyniszczenie jest wynikiem długotrwałego złożonego procesu patologicznego, w którym dochodzi do utraty tkanki mięśniowej, tłuszczowej i kostnej. Konsekwencją ubytku masy mięśniowej jest osłabienie siły mięśniowej i sprawności fizycznej, prowadząc do wzrostu ryzyka upadków co przy ubytku tkanki kostnej prowadzi do wzrostu ryzyka złamań i ich powikłań. Obecnie nie jest znany mechanizm prowadzący do wyniszczenia, ale zwraca się dodatkowo uwagę na wzrost spoczynkowego wydatku energetycznego, wzmożony katabolizm białkowy oraz nadprodukcję cytokin prozapalnych. Kacheksja w reumatoidalnym zapaleniu stawów uważana jest za czynnik pogarszający rokowanie zarówno co do przebiegu choroby, jak i przeżycia. Nie ma dotychczas opracowanych standardów postępowania leczniczego w kacheksji reumatoidalnej. Ćwiczenia wytrzymałościowe i siłowe, dostosowane do aktualnego stanu chorych, wydają się najbardziej skuteczną metodą zapobiegania utracie masy mięśniowej, natomiast wyniszczenie w przebiegu reumatologicznego zapalenia stawów wydaje się być oporne na terapię żywieniową i rozwija się nawet wobec prawidłowo zbilansowanej diety.

Full Text:

View PDF (Polish) Download PDF file
Get Citation

Keywords

reumatoidalne zapalenie stawów; kacheksja

About this article
Title

Kacheksja reumatoidalna

Journal

Rheumatology Forum

Issue

Vol 3, No 2 (2017)

Article type

Review paper

Pages

65-71

Published online

2017-06-20

Page views

1009

Article views/downloads

1778

Bibliographic record

Forum Reumatol 2017;3(2):65-71.

Keywords

reumatoidalne zapalenie stawów
kacheksja

Authors

Magdalena Krajewska-Włodarczyk
Włodzimierz Samborski

References (67)
  1. Paget J. Nervous mimicry of organic diseases. Lancet. 1873; 2: 727–9.
  2. Roubenoff R, Roubenoff RA, Ward LM, et al. Rheumatoid cachexia: depletion of lean body mass in rheumatoid arthritis. Possible association with tumor necrosis factor. J Rheumatol. 1992; 19(10): 1505–1510.
    PubMed
  3. Kotler DP. Cachexia. Ann Intern Med. 2000; 133(8): 622–634.
    PubMed
  4. Evans WJ, Morley JE, Argilés J, et al. Cachexia: a new definition. Clin Nutr. 2008; 27(6): 793–799.
    CrossRefPubMed
  5. Muscaritoli M, Anker SD, Argilés J, et al. Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) "cachexia-anorexia in chronic wasting diseases" and "nutrition in geriatrics". Clin Nutr. 2010; 29(2): 154–159.
    CrossRefPubMed
  6. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. European Working Group on Sarcopenia in Older People. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010; 39(4): 412–423.
    CrossRefPubMed
  7. Kyle UG, Bosaeus I, De Lorenzo AD, et al. Composition of the ESPEN Working Group. Bioelectrical impedance analysis--part I: review of principles and methods. Clin Nutr. 2004; 23(5): 1226–1243.
    CrossRefPubMed
  8. Pahor M, Manini T, Cesari M. Sarcopenia: clinical evaluation, biological markers and other evaluation tools. J Nutr Health Aging. 2009; 13(8): 724–728.
    PubMed
  9. Svenson KL, Pollare T, Lithell H, et al. Impaired glucose handling in active rheumatoid arthritis: relationship to peripheral insulin resistance. Metabolism. 1988; 37(2): 125–130.
    PubMed
  10. Chung CP, Oeser A, Solus JF, et al. Inflammation-associated insulin resistance: differential effects in rheumatoid arthritis and systemic lupus erythematosus define potential mechanisms. Arthritis Rheum. 2008; 58(7): 2105–2112.
    CrossRefPubMed
  11. Engvall IL, Elkan AC, Tengstrand B, et al. Cachexia in rheumatoid arthritis is associated with inflammatory activity, physical disability, and low bioavailable insulin-like growth factor. Scand J Rheumatol. 2008; 37(5): 321–328.
    CrossRefPubMed
  12. Elkan AC, Engvall IL, Cederholm T, et al. Malnutrition in women with rheumatoid arthritis is not revealed by clinical anthropometrical measurements or nutritional evaluation tools. Eur J Clin Nutr. 2008; 62(10): 1239–1247.
    CrossRefPubMed
  13. Roubenoff R, Roubenoff RA, Cannon JG, et al. Rheumatoid cachexia: cytokine-driven hypermetabolism accompanying reduced body cell mass in chronic inflammation. J Clin Invest. 1994; 93(6): 2379–2386.
    CrossRefPubMed
  14. Rall LC, Rosen CJ, Dolnikowski G, et al. Protein metabolism and its mediators before and after strength training in aging and chronic inflammation. Arthritis Rheum. 1996; 39: 1115–24.
  15. Arshad A, Rashid R, Benjamin K. The effect of disease activity on fat-free mass and resting energy expenditure in patients with rheumatoid arthritis versus noninflammatory arthropathies/soft tissue rheumatism. Mod Rheumatol. 2007; 17(6): 470–475.
    CrossRefPubMed
  16. Roubenoff R, Walsmith J, Lundgren N, et al. Low physical activity reduces total energy expenditure in women with rheumatoid arthritis: implications for dietary intake recommendations. Am J Clin Nutr. 2002; 76(4): 774–779.
    PubMed
  17. Binymin K, Herrick Al, Carlson Gl, et al. The effect of disease activity on body composition and resting energy expenditure in patients with rheumatoid arthritis. J Inflamm Res. 2011; 4: 61–66.
    CrossRefPubMed
  18. Henchoz Y, Bastardot F, Guessous I, et al. Physical activity and energy expenditure in rheumatoid arthritis patients and matched controls. Rheumatology (Oxford). 2012; 51(8): 1500–1507.
    CrossRefPubMed
  19. Morley JE, Thomas DR, Wilson MMG. Cachexia: pathophysiology and clinical relevance. Am J Clin Nutr. 2006; 83(4): 735–743.
    PubMed
  20. Rall LC, Roubenoff R. Rheumatoid cachexia: metabolic abnormalities, mechanisms and interventions. Rheumatology (Oxford). 2004; 43(10): 1219–1223.
    CrossRefPubMed
  21. Walsmith J, Abad L, Kehayias J, et al. Cachexia in rheumatoid arthritis. Int J Cardiol. 2002; 85(1): 89–99.
    PubMed
  22. van Bokhorst-de van der Schueren MAE, Konijn NPC, Bultink IEM, et al. Relevance of the new pre-cachexia and cachexia definitions for patients with rheumatoid arthritis. Clin Nutr. 2012; 31(6): 1008–1010.
    CrossRefPubMed
  23. Morley JE, Thomas DR, Wilson MMG. Cachexia: pathophysiology and clinical relevance. Am J Clin Nutr. 2006; 83(4): 735–743.
    PubMed
  24. Rall LC, Walsmith JM, Snydman L, et al. Cachexia in rheumatoid arthritis is not explained by decreased growth hormone secretion. Arthritis Rheum. 2002; 46(10): 2574–2577.
    CrossRefPubMed
  25. Ibañez De Cáceres I, Villanúa MA, Soto L, et al. IGF-I and IGF-I-binding proteins in rats with adjuvant-induced arthritis given recombinant human growth hormone. J Endocrinol. 2000; 165(3): 537–544.
    PubMed
  26. López-Otín C, Blasco MA, Partridge L, et al. The hallmarks of aging. Cell. 2013; 153(6): 1194–1217.
    CrossRefPubMed
  27. Schakman O, Gilson H, Thissen JP. Mechanisms of glucocorticoid-induced myopathy. J Endocrinol. 2008; 197(1): 1–10.
    CrossRefPubMed
  28. Rall LC, Meydani SN, Kehayias JJ, et al. The effect of progressive resistance training in rheumatoid arthritis. Increased strength without changes in energy balance or body composition. Arthritis Rheum. 1996; 39(3): 415–426.
    PubMed
  29. Roubenoff R, Roubenoff RA, Ward LM, et al. Catabolic effects of high-dose corticosteroids persist despite therapeutic benefit in rheumatoid arthritis. Am J Clin Nutr. 1990; 52(6): 1113–1117.
    PubMed
  30. Marcora SM, Lemmey AB, Maddison PJ. Can progressive resistance training reverse cachexia in patients with rheumatoid arthritis? Results of a pilot study. J Rheumatol. 2005; 32(6): 1031–1039.
    PubMed
  31. Marcora SM, Chester KR, Mittal G, et al. Randomized phase 2 trial of anti-tumor necrosis factor therapy for cachexia in patients with early rheumatoid arthritis. Am J Clin Nutr. 2006; 84(6): 1463–1472.
    PubMed
  32. Marcora S, Lemmey A, Maddison P. Dietary treatment of rheumatoid cachexia with beta-hydroxy-beta-methylbutyrate, glutamine and arginine: a randomised controlled trial. Clin Nutr. 2005; 24(3): 442–454.
    CrossRefPubMed
  33. Koutedakis Y, Begum S, Labib M, et al. Causes of cachexia in rheumatoid arthritis. Br J Rheumatol. 1996; 35: 200.
  34. Metsios GS, Stavropoulos-Kalinoglou A, Douglas KMJ, et al. Blockade of tumour necrosis factor-alpha in rheumatoid arthritis: effects on components of rheumatoid cachexia. Rheumatology (Oxford). 2007; 46(12): 1824–1827.
    CrossRefPubMed
  35. Metsios GS, Stavropoulos-Kalinoglou A, Nevill AM, et al. Cigarette smoking significantly increases basal metabolic rate in patients with rheumatoid arthritis. Ann Rheum Dis. 2008; 67(1): 70–73.
    CrossRefPubMed
  36. Stavropoulos-Kalinoglou A, Metsios GS, Koutedakis Y, et al. Redefining overweight and obesity in rheumatoid arthritis patients. Ann Rheum Dis. 2007; 66(10): 1316–1321.
    CrossRefPubMed
  37. Munro R, Capell H. Prevalence of low body mass in rheumatoid arthritis: association with the acute phase response. Ann Rheum Dis. 1997; 56(5): 326–329.
    PubMed
  38. Helliwell M, Coombes EJ, Moody BJ, et al. Nutritional status in patients with rheumatoid arthritis. Ann Rheum Dis. 1984; 43(3): 386–390.
    PubMed
  39. Kennedy AC, Boddy K, Williams ED, et al. Whole body elemental composition during drug treatment of rheumatoid arthritis: a preliminary study. Ann Rheum Dis. 1979; 38(2): 137–140.
    PubMed
  40. Helliwell PS, Jackson S. Relationship between weakness and muscle wasting in rheumatoid arthritis. Ann Rheum Dis. 1994; 53(11): 726–728.
    PubMed
  41. Mody GM, Brown GM, Meyers OL, et al. Nutritional assessment in rheumatoid arthritis. S Afr Med J. 1989; 76(6): 255–257.
    PubMed
  42. Haugen M, Homme KA, Reigstad A, et al. Assessment of nutritional status in patients with rheumatoid arthritis and osteoarthritis undergoing joint replacement surgery. Arthritis Care Res. 1999; 12(1): 26–32.
    PubMed
  43. Toussirot E, Nguyen NU, Dumoulin G, et al. Relationship between growth hormone-IGF-I-IGFBP-3 axis and serum leptin levels with bone mass and body composition in patients with rheumatoid arthritis. Rheumatology (Oxford). 2005; 44(1): 120–125.
    CrossRefPubMed
  44. Westhovens R, Nijs J, Taelman V, et al. Body composition in rheumatoid arthritis. Br J Rheumatol. 1997; 36(4): 444–448.
    PubMed
  45. Blackman MR, Muniyappa R, Wilson M, et al. Diurnal secretion of growth hormone, cortisol, and dehydroepiandrosterone in pre- and perimenopausal women with active rheumatoid arthritis: a pilot case-control study. Arthritis Res Ther. 2007; 9(4): R73.
    CrossRefPubMed
  46. Sahin G, Guler H, Incel N, et al. Soft tissue composition, axial bone mineral density, and grip strength in postmenopausal Turkish women with early rheumatoid arthritis: Is lean body mass a predictor of bone mineral density in rheumatoid arthritis? Int J Fertil Womens Med. 2006; 51(2): 70–74.
    PubMed
  47. Shibuya K, Hagino H, Morio Y, et al. Cross-sectional and longitudinal study of osteoporosis in patients with rheumatoid arthritis. Clin Rheumatol. 2002; 21(2): 150–158.
    PubMed
  48. Wallace LS, Ballard JE, Holiday DB, et al. Comparison between 60 matched pairs of postmenopausal black and white women: analysis of risk factors related to bone mineral density. Maturitas. 2005; 52(3-4): 356–363.
    CrossRefPubMed
  49. Häkkinen A, Pakarinen A, Hannonen P, et al. Effects of prolonged combined strength and endurance training on physical fitness, body composition and serum hormones in women with rheumatoid arthritis and in healthy controls. Clin Exp Rheumatol. 2005; 23(4): 505–512.
    PubMed
  50. Sambrook PN, Spector TD, Seeman E, et al. Osteoporosis in rheumatoid arthritis. A monozygotic co-twin control study. Arthritis Rheum. 1995; 38(6): 806–809.
    PubMed
  51. Madsen OR, Egsmose C, Hansen B, et al. Soft tissue composition, quadriceps strength, bone quality and bone mass in rheumatoid arthritis. Clin Exp Rheumatol. 1998; 16(1): 27–32.
    PubMed
  52. Kalla AA, Brown G, Meyers OL. Nutritional status in rheumatoid arthritis. Effects of disease activity, corticosteroid therapy and functional impairment. S. Afr. Med. J. 1992; 82: 411–44.
  53. Inaba M, Tanaka K, Goto H, et al. Independent association of increased trunk fat with increased arterial stiffening in postmenopausal patients with rheumatoid arthritis. J Rheumatol. 2007; 34(2): 290–295.
    PubMed
  54. Hernandez-Beriain JA, Segura-Garcia C, Rodriguez-Lozano B, et al. Undernutrition in rheumatoid arthritis patients with disability. Scand J Rheumatol. 1996; 25(6): 383–387.
    PubMed
  55. Fukuda W, Yamazaki T, Akaogi T, et al. Malnutrition and disease progression in patients with rheumatoid arthritis. Mod Rheumatol. 2005; 15(2): 104–107.
    CrossRefPubMed
  56. Engelhart M, Kondrup J, Høie LH, et al. Weight reduction in obese patients with rheumatoid arthritis, with preservation of body cell mass and improvement of physical fitness. Clin Exp Rheumatol. 1996; 14(3): 289–293.
    PubMed
  57. Ellis KJ. Human body composition: in vivo methods. Physiol Rev. 2000; 80(2): 649–680.
    PubMed
  58. Elkan AC, Håkansson N, Frostegård J, et al. Rheumatoid cachexia is associated with dyslipidemia and low levels of atheroprotective natural antibodies against phosphorylcholine but not with dietary fat in patients with rheumatoid arthritis: a cross-sectional study. Arthritis Res Ther. 2009; 11(2): R37.
    CrossRefPubMed
  59. B. A. Resistance Training for Patients with Rheumatoid Arthritis: Effects on Disability, Rheumatoid Cachexia, and Osteoporosis; and Recommendations for Prescription. Rheumatoid Arthritis - Treatment. 2012.
    CrossRef
  60. Dessein PH, Joffe BI, Stanwix AE. Effects of disease modifying agents and dietary intervention on insulin resistance and dyslipidemia in inflammatory arthritis: a pilot study. Arthritis Res. 2002; 4(6): R12.
    CrossRefPubMed
  61. Ferraz-Amaro I, González-Juanatey C, López-Mejias R, et al. Metabolic syndrome in rheumatoid arthritis. Mediators Inflamm. 2013; 2013: 710928.
    CrossRefPubMed
  62. Elkan AC, Engvall IL, Cederholm T, et al. Rheumatoid cachexia, central obesity and malnutrition in patients with low-active rheumatoid arthritis: feasibility of anthropometry, Mini Nutritional Assessment and body composition techniques. Eur J Nutr. 2009; 48(5): 315–322.
    CrossRefPubMed
  63. Chen CY, Tsai CY, Lee PC, et al. Long-term etanercept therapy favors weight gain and ameliorates cachexia in rheumatoid arthritis patients: roles of gut hormones and leptin. Curr Pharm Des. 2013; 19(10): 1956–1964.
    PubMed
  64. Hurkmans E, van der Giesen FJ, Vliet Vlieland TPm, et al. Dynamic exercise programs (aerobic capacity and/or muscle strength training) in patients with rheumatoid arthritis. Cochrane Database Syst Rev. 2009(4): CD006853.
    CrossRefPubMed
  65. Sharif S, Thomas JM, Donley DA, et al. Resistance exercise reduces skeletal muscle cachexia and improves muscle function in rheumatoid arthritis. Case Rep Med. 2011; 2011: 205691.
    CrossRefPubMed
  66. Baillet A, Vaillant M, Guinot M, et al. Efficacy of resistance exercises in rheumatoid arthritis: meta-analysis of randomized controlled trials. Rheumatology (Oxford). 2012; 51(3): 519–527.
    CrossRefPubMed
  67. Mikkelsen UR, Couppé C, Karlsen A, et al. Life-long endurance exercise in humans: circulating levels of inflammatory markers and leg muscle size. Mech Ageing Dev. 2013; 134(11-12): 531–540.
    CrossRefPubMed

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl